Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High-Risk Otolaryngologic Devices, 2000-2014. | EBSCOhost

Connecting you to content on EBSCOhost

Title: Clinical Evidence Supporting US Food and Drug Administration Premarket Approval of High-Risk Otolaryngologic Devices, 2000-2014.
Authors: Rathi, Vinay K.; Bo Wang; Ross, Joseph S.; Downing, Nicholas S.; Kesselheim, Aaron S.; Gray, Stacey T.; Wang, Bo
Publication: Otolaryngology-Head & Neck Surgery, 2017, Vol 156, Issue 2, p285
ISSN: 0194-5998
Publication type: Academic Journal
DOI: 10.1177/0194599816684094